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Application of in vivo expression technology (IVET) to Yersinia ruckeri, an important fish pathogen, allowed
the identification of two adjacent genes that represent a novel bacterial system involved in the uptake and
degradation of L-cysteine. Analysis of the translational products of both genes showed permease domains (open
reading frame 1 [ORF1]) and amino acid position identities (ORF2) with the L-cysteine desulfidase from
Methanocaldococcus jannaschii, a new type of enzyme involved in the breakdown of L-cysteine. The operon was
named cdsAB (cysteine desulfidase) and is found widely in anaerobic and facultative bacteria. cdsAB promoter
analysis using lacZY gene fusion showed highest induction in the presence of L-cysteine. Two cdsA and cdsB
mutant strains were generated. The limited toxic effect and the low utilization of L-cysteine observed in the cdsA
mutant, together with radiolabeled experiments, strongly suggested that CdsA is an L-cysteine permease. Fifty
percent lethal dose (LD50) and competence index experiments showed that both the cdsA and cdsB loci were
involved in the pathogenesis of the bacteria. In conclusion, this study has shown for the first time in bacteria
the existence of an L-cysteine uptake system that together with an additional L-cysteine desulfidase-encoding
gene constitutes a novel operon involved in bacterial virulence.
The genus Yersinia is known mainly because it includes three
important human pathogenic species, Yersinia pestis, Yersinia
pseudotuberculosis, and Yersinia enterocolitica, which have been
deeply studied in the last 20 years. However, the genus also
includes other species, such as Yersinia ruckeri, involved in
pathological processes in intensive aquaculture which cause
important economic losses in this kind of industry. This bac-
terium is the etiological agent of the enteric red mouth disease
of fish. This disease is spread throughout the world and affects
mainly the aquaculture of salmonids. Most of the mechanisms
involved in the virulence of Yersinia species that cause human
diseases are very well known. In contrast, only a few patho-
genic mechanisms of Y. ruckeri have been described (7, 12, 14,
29). The application to Y. ruckeri of in vivo expression technol-
ogy (IVET) has allowed the identification of 14 genes specif-
ically induced during the infection process in rainbow trout
(11). Some of them have been proven to participate in viru-
lence, such as the iron uptake mechanism via the catecholate
siderophore ruckerbactin (11), the YhlA hemolysin (13), and
the tra chromosomally located operon, a type IV secretion
system (22).
Cysteine is an important amino acid, because as a sulfur-
containing compound, it is the sole entrance for reduced sulfur
into cell metabolism in most organisms. Cysteine is essential
for the biogenesis of Fe-S clusters of some enzymes; it also
plays a crucial role in protein folding through disulfide bond
formation, and the sulfur component is needed for synthesis of
essential compounds, such as methionine, thiamine, biotin, etc.
This amino acid residue also represents the rate-limiting nu-
trient in glutathione biosynthesis (1, 34), the major redox
buffer and detoxification molecule in the cell. In spite of these
important roles of cysteine, an increased cysteine level has
been shown to be toxic to cells (18, 19, 26). For this reason, the
intracellular cysteine levels need to be tightly regulated, by
controlling not only its biosynthesis and degradation but also
the transport of this amino acid from the extracellular medium
to the cell and vice versa. In contrast to eukaryotes, cysteine
uptake has been poorly characterized in bacteria (10, 24, 32).
These systems are rare in prokaryotes, in part because this
amino acid is readily oxidized to the disulfide-linked cystine
and taken up in this form. For this reason, cystine uptake has
been further studied (5, 6, 17).
There are several types of cysteine-degrading enzymes in
bacteria. These include L-cysteine desulfurase (EC 2.8.1.7)
and D-cysteine desulfhydrase (EC 4.4.1.15), both pyridoxal
phosphate-dependent enzymes. Recently, a new type of L-
cysteine-degrading enzyme has been described in the ar-
chaeal Methanocaldococcus jannaschii (33). This was de-
fined as L-cysteine desulfidase and uses the [4Fe-4S] center
instead of pyridoxal phosphate to catalyze the hydrolysis of
L-cysteine to sulfide, ammonia, and pyruvate. The enzyme
was oxygen sensitive, and on the basis of sequence compar-
ison it was found that this protein was widely present in
anaerobic bacteria (33).
In this paper, the analysis of a previously selected iviX clone
(11) showed the presence in Y. ruckeri of a novel two-compo-
nent operon involved in the assimilation of L-cysteine. Accord-
ing to sequence analysis, the first gene corresponds to an
amino acid permease and the second to an L-cysteine desulfi-
dase. Regulation studies and uptake experiments confirm the
involvement of this system in the cysteine metabolism of the
bacterium. Interestingly, the operon is needed for full viru-
lence of Y. ruckeri in fish.
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MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The bacterial strains and
plasmids used in this work are listed in Table 1. Y. ruckeri strains were routinely
cultured in nutrient broth (NB; Difco) and on nutrient agar (NB with 1.5% agar)
(NA) and M9 medium supplemented with 0.5% glucose (Scharlau Chemie S.A.)
and 0.2% Casamino Acids (Becton, Dickinson and Company) (M9GC) at 18°C
or 28°C. Escherichia coli strains were cultured in 2 tryptone-yeast extract (TY)
broth or agar. In order to avoid L-cysteine oxidation, the bacteria were incubated
in 50-ml Falcon screw-top airtight tubes containing 20 ml of medium. Under this
condition, L-cysteine was stable as determined by the ninhydrin quantification
method (16) (see below).
For incubation under aerobic conditions, 250-ml Erlenmeyer flasks containing
20 ml of medium were inoculated with the bacteria and incubated in an orbital
shaker at 250 rpm. If required, the following antibiotics were added to the
medium: 100 g/ml ampicillin, 50 g/ml rifampin, 50 g/ml streptomycin, and 50
g/ml kanamycin, all of them from Sigma-Aldrich Co. Growth was monitored by
determining the optical density at 600 nm (OD600) of a culture with a Hitachi
U-2900 spectrophotometer at different times during incubation at the appropri-
ate temperature.
Genetic techniques. Routine DNA manipulation was performed as described
by Sambrook and Russell (30). Phage T4 DNA ligase and calf intestinal alkaline
phosphatase were purchased from Roche Ltd., restriction enzymes were from
Takara Bio Inc., and oligonucleotides were from Sigma-Aldrich Co.
DNA sequencing was performed by the dideoxy chain termination method
with the BigDye Terminator version 3.1 (Applied Biosystems) according to the
manufacturer’s instructions in an ABI Prism 3130xl DNA sequencer at the
Universidad de Oviedo. Sequences were compared to those in the databases with
the BLAST (Basic Local Alignment Search Tool) program.
Plasmid DNA from clone iviX was recovered from the Y. ruckeri chromosome
by triparental mating (11), and the DNA fragment situated upstream of the cat
and bla genes was sequenced using the initial primer catseq-2 (5-CGGTGGT
ATATCCAGTG-3), corresponding to nucleotides 31 to 15 of the cat gene from
the pIVET8 plasmid (11).
In vitro regulation studies. Cells of Y. ruckeri 150RiviX containing a
cdsB::pIVET8 transcriptional fusion were incubated in the presence of different
amino acids, such as L-serine, L-leucine, L-threonine, L-methionine, L-tryptophan,
L-tyrosine, L-cysteine, and L-cystine, at concentrations of 0.5 mM and 20 mM in
screw-top airtight tubes and flasks containing M9GC medium supplemented with
100 g/ml ampicillin up to an OD600 of about 1.0. Cells were centrifuged at
12,000  g for 5 min, and -galactosidase activity was assayed in cells by the
Miller method (23) using o-nitrophenyl--D-galactopyranoside (ONPG) as a
substrate. For the analysis of the maximal L-cysteine concentration required for
induction of the cdsAB operon, L-cysteine was included in the culture medium in
concentrations of 10 M, 25 M, 50 M, 100 M, 250 M, 0.5 mM, 1 mM, 2
mM, and 5 mM, and -galactosidase activity was assayed when culture reached
an OD600 of 1.0. For time course induction experiments, 0.5 mM L-cysteine was
added to the culture medium, and at different times of incubation -galactosi-
dase activity was determined.
Construction of cdsA and cdsB mutants. Internal fragments of 525 and 529 bp
of the predicted cdsA and cdsB open reading frames (ORFs), respectively, were
amplified by PCR with the following primers: forward primer cdsA-1 (5-ATG
CGGATCCTATTAGGCGCACTTTAT-3), with nucleotides 347 to 363 of the
cdsA gene in bold type, and reverse primer cdsA-2 (5-ATGCGGATCCTTAAC
AGCTTCATCGTG-3), with nucleotides 881 to 865 in bold type, to amplify the
internal fragment of the cdsA gene; forward primer cdsB-1 (5-ATGCAGATCT
CGATACAGGAGAGTGAT-3), with nucleotides 356 to 372 in bold type, and
reverse primer cdsB-2 (5-ATGCAGATCTAGATATTCGGCCACCAC-3), with
nucleotides 884 to 868 in bold type, to amplify the internal fragment of cdsB.
Primers contained restriction sites for BamHI and BglII, in italics, and four
additional bases at their 5 end. The amplicons generated were digested with the
corresponding enzymes and ligated into pJP5603 previously digested with
BamHI and dephosphorylated. The ligation mixture was used to transform
electrocompetent cells of E. coli S17-1pir. Selected transformants, containing
the plasmid with the insert, were used to conjugate with Y. ruckeri 150R to obtain
the cdsA::pJP5603 and cdsB::pJP5603 mutants, as previously described (14). The
mutations were confirmed by Southern blot analysis after digestion of genomic
DNA with EcoRI of the parental strain and the cdsA and cdsB mutants. The
previously amplified internal fragments from cdsA and cdsB were used as probes.
Probe labeling, hybridization, and developing were performed with the DIG
DNA labeling and detection kit from Roche by following the manufacturer’s
instructions. The stability of the mutants in the absence of kanamycin was
analyzed by doing several passes on nonselective medium, followed by compar-
ison of the number of cells able to grow on plates with or without antibiotic.
To complete the sequence of cdsB, genomic DNA from the Y. ruckeri cdsB
mutant was digested with EcoRI, the only restriction site on the pJP5603 plas-
mid. The restriction fragments were religated, and the mixture was used to
transform cells of E. coli S17-1pir. Transformants were selected on 2 TY agar
medium containing kanamycin. The plasmid containing the cdsB gene was se-
quenced with the initial primer RP (5-CAGGAAACAGCTATGAC-3) from
the lacZ gene from the pJP5603 plasmid.
Growth studies and L-cysteine quantification. To check if cdsA and cdsB
mutations played any role in the growth of Y. ruckeri, wild-type and mutant
TABLE 1. Bacterial strains and plasmidsa
Strain or plasmid Relevant properties Source or reference
Strains
Yersinia ruckeri
150R Rifr derivative of strain 150 14
150RiviX Strain containing ivi fusion expressed only in the host 11
cdsA mutant Rifr cdsA::pJP5603 This work
cdsB mutant Rifr cdsB::pJP5603 This work
146, 147, 148, 149, and 150 Strains isolated from an outbreak in trout (Danish fish farm) J. L. Larsen (Denmark)
955, 956, and 43/19 Strains isolated from an outbreak in trout (U.S. fish farms) CECT (Spanish Type
Culture Collection)
35/85 and 13/86 Strains isolated from outbreaks in trout (Danish and United Kingdom
fish farms, respectively)
C. J. Rodgers, University
of Tarragona, Spain
A100 and A102 Strains isolated from outbreak in trout (Spanish fish farm) I. Ma´rquez, Laboratory
of Animal Health
150/05, 158/05, and 382/05 Strains isolated from outbreak in trout (Spanish fish farm) Proaqua Nutricio´n S.A.
Escherichia coli
S17-1pir Smr (pir) hsdR pro thi RP4-2 Tc::Mu Km::Tn7 31
MT1694 Helper strain HB101 containing pRK2013 15
Plasmids
pIVET8 Apr oriR6K mob promotorless cat-lacZY 20
pJP5603 Kanr oriR6K mob Plac promoter 27
pCdsA pJP5603::BamHI (cdsA), Kanr This work
pCdsB pJP5603::BamHI (cdsB), Kanr This work
a All Y. ruckeri strains with the exception of strain 956 (which belongs to serotype 2) belong to serotype 1. Rifr, rifampin resistance; Apr, ampicillin resistance; Smr,
streptomycin resistance; Kanr, kanamycin resistance.
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strains were incubated in 50-ml Falcon screw-top airtight tubes containing
M9GC and M9GC supplemented with 0.5 mM L-cysteine. Growth was moni-
tored by determining the OD600 at different times during incubation at 18°C.
Growth curves were determined in triplicate and repeated three times. For
L-cysteine quantification in the supernatant of cultures at different incubation
times through the growth curve, the acid ninhydrin assay described by Gaitonde
(16) was used. Briefly, the content of this amino acid was determined colori-
metrically by monitoring the absorbance at 560 nm and reading from a standard
curve (r2  0.99). M9GC supplemented with 0.5 mM L-cysteine with no cells was
used as the control of the total amount of the amino acid in the medium. The
experiment was repeated three times, and the mean and standard deviation were
computed. Cystine (0.5 mM) was used as a negative control.
Amino acid transport assay. Y. ruckeri parental and cdsA strains were cultured
in 50-ml Falcon screw-top airtight tubes containing M9GC medium supple-
mented with 0.5 mM L-cysteine at 18°C up to an OD600 of 0.8. Thirty milliliters
of each strain was harvested, washed twice with buffer A, containing 100 mM
Tris-HCl (pH 7.3), 100 mM NaCl, and 0.5 mM MgCl2, and resuspended in 9 ml
of the same buffer. After 5 min in the presence of chloramphenicol (15 g/ml) to
inhibit protein synthesis, a solution containing 2 mM L-cysteine as a carrier, 20
Ci/ml of 35S-labeled L-cysteine (specific activity, 1,075 Ci/mmol) (Perkin Elmer,
Boston, MA), and 10 mM dithiothreitol was added (final concentrations of
L-cysteine and dithiothreitol were 200 M and 1 mM, respectively). Assays were
performed at 18°C, and duplicated samples of 0.5 ml were withdrawn at intervals,
diluted 20-fold in cold buffer A, and filtered through 25-mm-diameter GF/C
Millipore nitrocellulose membrane filters (0.45-m pore size). Filters were
washed with 10 ml of buffer A, dried, and immersed in Filter-Count scintillation
cocktail (Perkin Elmer, Boston, MA), and the radioactivity was measured in a
liquid scintillation counter. L-Cysteine uptake activity was calculated in nmol/
min/mg protein. Total protein was quantified by the Bradford (AppliChem,
Germany) protein method.
For competition studies, the different amino acids were added in 10-fold excess
in relation to cysteine, except cystine, which was insoluble in buffer A at this
concentration, and a 1:1 ratio was used. The rate of L-cysteine uptake was
measured in a 5-min reaction. The proton gradient inhibitor carbonyl cyanide
m-chlorophenylhydrazone (CCCP) was added to the cells 10 min before the
labeled compound.
Experimental animal studies. To determine the role in virulence of cdsA and
cdsB mutations, 50% lethal dose (LD50) experiments with the parental and the
mutant strains were carried out as described by Ferna´ndez et al. (14). Rainbow
trout (Oncorhynchus mykiss) weighing between 8 and 10 g were kept in 60-liter
tanks at 18  1°C in continually flowing dechlorinated water. Groups of 10 fish
were challenged by intraperitoneal injection of 0.1 ml serial 10-fold dilutions of
an exponential-phase culture of bacteria in phosphate-buffered saline (PBS) over
a range of 102 to 108 cells, and the mortalities were followed up for 7 days.
Control fishes were injected with 0.1 ml PBS. Two different experiments were
carried out, and the LD50 determinations were calculated by the method of Reed
and Muench (28).
For in vivo competition assays, parental and mutant strains were grown sep-
arately in NB at 18°C in orbital shakers at 250 rpm up to an OD600 of 0.5
(approximately 108 cells/ml). Two and a half milliliters of parental and mutant
strains were mixed, and 10-fold dilutions of this suspension were plated onto NA
(to measure total CFU) and NA containing kanamycin (to determine mutant
CFU). From this, the exact input ratio of mutant to wild-type CFU was calcu-
lated. A sample of 0.1 ml of the 10	2 dilution of both mixes (parental/cdsA or
parental/cdsB mutant strains; approximately 106 cells/ml of each strain) was used
to infect rainbow trout weighing from 8 to 10 g by intraperitoneal injection. After
72 h, spleen, liver, and intestine from each infected fish were homogenized
together in NB with a stomacher. Aliquots of the suspensions were plated onto
NA and NA containing kanamycin as a selective medium to determine the
output ratio of mutant to parental cells. In each experiment, three fish were used,
and the competence index (CI) was determined as the mean of data of the three
fish. The experiment was repeated twice, and the mean and standard deviation
were determined. The competence index is defined as the output ratio (mutant/
parental) divided by the input ratio (mutant/parental). Animal experiments were
performed in accordance with the European legislation governing animal wel-
fare, and they were authorized and supervised by the Animal Experimentation
Ethics Committee of Universidad de Oviedo.
PCR detection of cdsA and cdsB in different Y. ruckeri strains. Fifteen Y. ruckeri
strains were studied in regard to the presence of cdsA and cdsB genes. PCR was
performed using the following primers: DetC-1 (5-ATGCGGATCCTTTCATT
ATGTTAGTTA-3) and DetC-2 (5-CCATTATTCCATTTTGA-3) to check
the presence of the cdsA gene, and cdsB-1 and cdsB-2 (described previously) to
check the presence of the cdsB gene. All PCR components (DNA polymerase,
reaction buffer, and deoxynucleoside triphosphates) were provided by Biotools.
The amplification reactions were performed in a Perkin-Elmer 9700 GeneAmp
thermocycler with an initial denaturation cycle at 94°C for 5 min, followed by 25
cycles of amplification (denaturation at 94°C for 30 s, annealing at 38°C for cdsA
and 44°C for cdsB for 60 s, and extension at 72°C for 1 min), and a final 7-min
elongation step at 72°C. The reaction products corresponding to the two groups
were mixed, and 1.5% agarose gel electrophoresis was used to separate the
generated PCR amplicons.
Nucleotide sequence accession number. The GenBank/EMBL/DDBJ acces-
sion number for the sequences reported in this paper is HM769941.
RESULTS
CdsB shows conserved amino acid positions with respect to
L-cysteine desulfidase enzyme. Selection of specific in vivo-
induced genes in Y. ruckeri was previously carried out by IVET
(11). One out of 14 isolated clones, the iviX, contained an in
vivo-induced transcriptional fusion (Fig. 1) with a partial ORF
encoding a protein which showed a significant similarity with
hypothetical transmembrane proteins from different bacteria
(11). Further sequencing and analysis of the adjacent region of
this genetic locus revealed the presence of an additional ORF
separated by 49 bp and proceeded by a consensus 	10 (TT
TAAT) and 	35 (CAGATA) promoter sequence and a ribo-
some binding site (RBS) (AGGCGA). The upstream gene
consists of 1,326 bp and encodes a protein of 442 amino acids
which shares a high identity with hypothetical proteins of Y.
ruckeri ATCC 29473 (442/442 [100%]), Y. enterocolitica (418/
442 [94%]), Salmonella enterica serovar Typhimurium LT2
(389/445 [87%]), and Citrobacter koseri (387/445 [86%]) and
with the protein YhaO of Escherichia coli B (162/175 [92%]).
The translational compound encoded by the first ORF shows
11 transmembrane helixes (putative membrane localization)
and a conserved domain related to transmembrane amino acid
transporter proteins. The second ORF of 1,323 bp encodes a
protein of 441 amino acids which shares high identity with
hypothetical proteins of Y. ruckeri ATCC 29473 (441/441
[100%]), Y. enterocolitica (329/439 [74%]), Escherichia albertii
TWO7627 (300/440 [68%]), and Salmonella enterica
CT-02021853 (296/440 [67%]) and the protein YhaM CFTO73
of Escherichia coli B (297/441 [67%]). It encodes a protein
FIG. 1. Chromosomal arrangement of the region containing cdsA
and cdsB genes in Y. ruckeri 150R. Arrows indicate the direction of the
transcription. The organization of the transcriptional fusion between
cdsB and the promoterless genes cat and lacZY in Y. ruckeri 150RiviX
is shown underneath, and the putative promoter (P) selected by IVET
is indicated. Catseq-2 oligonucleotide was used to sequence the frag-
ments adjacent to the pIVET8 integration site. cat, chloramphenicol
acetyltransferase gene (promoterless); lacZY, genes for lactose fer-
mentation (promoterless); bla, ampicillin resistance gene.
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which presents two conserved domains: COG3681 (L-cysteine
desulfidase) and cI12120 (L-serine dehydratase, iron-sulfur-de-
pendent, alpha subunit). Similar domains exist in the L-cysteine
desulfidase of M. jannaschii, which catalyzes the breakdown of
L-cysteine into pyruvate, ammonia, and sulfide (33). In fact, the
protein encoded by the second ORF in Y. ruckeri presents 28 out
of 29 amino acids conserved in specific positions of the L-cysteine
desulfidase of M. jannaschii, including the four cysteines (C27,
C327, C366, and C373) described by Tchong et al. as possible
ligands for the [3Fe-4S] center (33) (Fig. 2). The differential
amino acid position corresponds to P346 in Y. ruckeri, and it also
differs from M. jannaschii in other orthologous loci found in Y.
enterocolitica, Klebsiella pneumoniae, and Proteus mirabilis, among
others (Fig. 2). On the basis of these amino acid identities and
domains as well as other results shown below, from now on the
two ORFs identified from the analysis of the iviX clone are des-
ignated cdsB (cysteine desulfidase) and cdsA, for ORF2 and
ORF1, respectively.
cdsA and cdsB orthologs are present in several bacterial
groups. Comparative nucleotide sequence analysis using the
BLAST program showed that similar cdsAB clusters were present
in C. koseri ATCC BAA-895 (CKO_04511 and CKO_04510),
S. enterica subsp. enterica serovar Typhimurium strain LT2
(yhaO and yhaN), Shigella sonnei Ss046 (yhaO and yhaNM),
Escherichia coli B strain REL606 (yhaO and yhaM), Dich-
elobacter nodosus VCS1703A (DNO_0107 and DNO_0106),
Chromobacterium violaceum ATCC 12472 (CV_1823 and
CV_1824), and Y. enterocolitica subsp. enterocolitica 8081
(YE0447 and YE0448) (Fig. 3). However, the cluster was ab-
sent from species closely related to Y. ruckeri and Y. enteroco-
litica, such as Y. pseudotuberculosis IP 32953 and Y. pestis
CO92. These two species present similar cdsA loci (YPTB0334
FIG. 2. Conserved residues among the orthologs of CdsB. GenBank data accession numbers correspond to M. jannaschii (MJ1025), Y.
enterocolitica (YE0448), K. pneumoniae (KPN_04419), P. mirabilis (PMI0145), and D. nodosus (DNO_0106). Note that the amino acid variations
correspond with position 346 of the CdsB protein. An additional variation is found in the 311 position of D. nodosus (DNO_0106). The four
cysteines C27, C327, C366, and C373 described by Tchong et al. (33) as possible ligands for the [3Fe-4S] center are underlined.
FIG. 3. Phylogenetic tree based on the CdsB protein sequence, showing the relationships between Y. ruckeri and its other relatives. GenBank
data accession numbers are indicated: Y. enterocolitica (YE0448), Escherichia coli (YHAM), Shigella sonnei Ss046 (YP_312078), Salmonella enterica
(NP_462152), Citrobacter koseri (YP_001456001), Chromobacterium violaceum (CV_1824), Dichelobacter nodosus (DNO_0106), Proteus mirabilis
(PMI0145), Treponema denticola (TDE2144), Aeromonas hydrophila (YP858502), Lactobacillus sakei (YP_394765), Actinobacillus pleuropneumo-
niae (ZP_00133782), Methanocaldococcus jannaschii (MJ1025), Methanococcus maripaludis (MMP1468), Fusobacterium nucleatum (FN1147),
Thermoanaerobacter tengcongensis (TTE0269), Clostridium perfringens (CPE0806), Geobacter sulfurreducens (GSU1527), Desulfitobacterium hafni-
ense (DSY1109), Vibrio parahaemolyticus (VP2173), Porphyromonas gingivalis (PG0909), Klebsiella pneumoniae (YP_001338041), Bacteroides
thetaiotaomicron (BT2080), Desulfovibrio desulfuricans (Dde_0807), Shewanella oneidensis (SO_1403), and Clostridium tetani (CTC02309). Note
that the species grouped in the first division from CdsB of Y. ruckeri to DNO_0106 of Dichelobacter nodosus presented a cdsAB orthologous operon
in their genome. The large black box groups the species close to Y. ruckeri which harbor the cdsAB cluster.
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and YPO0277, respectively) in their genomes, but these are
followed by the metC gene, which encodes a cystathionine
-lyase. Interestingly, this enzyme also catalyzes the degra-
dation of L-cysteine to pyruvate, ammonia, and sulfide in
Escherichia coli (3). A second group of bacteria, including
M. jannaschii, was found in which the cdsB locus was not
preceded by the corresponding cdsA locus. A phylogenetic
analysis based on CdsB protein sequence showed the rela-
tionship between Y. ruckeri and its other relatives (Fig. 3).
The cdsAB operon is induced specifically by L-cysteine. The
strain Y. ruckeri 150RiviX, obtained by IVET, contains a tran-
scriptional fusion between the cdsAB promoter and lacZY (Fig.
1). This construction was used for the analysis of the expression
of these genes in response to different culture conditions. The
results obtained by -galactosidase activity determination in
cultures grown in 50-ml Falcon screw-top airtight tubes con-
taining M9GC medium showed that L-cysteine and L-cystine
were the only promoter inductors. Specifically, -galactosidase
activity was increased approximately 4-fold in the presence of
0.5 mM concentrations of these amino acids. This increase was
detected in both exponential- and stationary-phase cultures.
The catabolism of these amino acids produced the generation
of abundant H2S, as was determined by its characteristic un-
pleasant odor and the production of a black precipitate after
culture centrifugation when an iron salt was included in the
culture medium. It should be noticed that during incubation
under these conditions and in the presence of a reducing agent
such as H2S, which changed the redox potential of cultures,
L-cystine turned into L-cysteine, as was determined by the nin-
hydrin method (data not shown). This, together with the lim-
ited induction (1.7-fold) observed in the presence of L-cysteine
when incubation was carried out under oxygenation conditions,
in which L-cysteine is turned into L-cystine, strongly suggests
that L-cysteine is the unique operon inductor, and a progressive
increase in -galactosidase activity was found until a maximum
at a 1 mM concentration of the amino acid. Other amino acids,
such as leucine, serine, threonine, tryptophan, tyrosine, and
methionine, in both low (0.5 mM) and high (20 mM) concen-
trations, did not significantly induce the promoter.
The cdsA mutant but not the cdsB mutant is more resistant
to L-cysteine than the parental strain due to an alteration in
L-cysteine uptake. To investigate the relative roles of the
cdsAB operon in bacterial physiology, two mutants with inde-
pendent mutations in cdsA and cdsB were constructed by in-
sertional mutagenesis as described by Ferna´ndez et al. (11).
PCR and Southern blot analysis showed that the genes cdsA
and cdsB were inactivated in the respective mutants, and
both were genetically stable under nonselective antibiotic
pressure (data not shown). No differences in growth were
detected between the parental and the mutant strains (cdsA
and cdsB mutants) when they were grown in screw-top air-
tight tubes containing M9GC or in M9GC supplemented
with specific amino acids, such as threonine, serine, trypto-
phan, or tyrosine. A similar result was obtained when the
complex medium NB was used. However, the parental and
the cdsB mutant strains showed a significant growth limita-
tion in medium containing 0.5 mM cysteine, while the cdsA
mutant partially overcame this growth limitation (Fig. 4).
To determine if the partial resistance of the cdsA mutant to
cysteine was a consequence of a limited consuming capacity of
this amino acid, the cysteine present in the medium was quan-
tified during the growth curves of Y. ruckeri parental and mu-
tant strains in M9GC medium plus 0.5 mM cysteine. As can be
observed in Table 2, the cysteine remaining in the culture
medium after 48 h of incubation was considerably higher in the
cdsA mutant than in the parental and cdsB mutant strains. This
difference was observed along the whole growth curve. There-
fore, the limited toxic effect that cysteine has in the growth of
the cdsA mutant, together with its limited capacity for cysteine
consumption, suggests that the cdsA gene encodes a cysteine
permease.
In order to confirm the role of CdsA in cysteine uptake,
studies using [35S]L-cysteine were carried out. Cells of the cdsA
mutant and parental strains were grown in the presence of 0.5
mM cysteine, and at mid-logarithmic-growth phase (OD600 
0.7 to 0.8) cysteine uptake was measured. When the kinetics of
L-cysteine uptake were determined in the presence of a 200
M concentration of this amino acid, the results showed a
significant delay in the uptake of radiolabeled cysteine in the
cdsA mutant compared to that in the parental strain (Fig. 5).
To define the substrate specificity of CdsA, competitive
transport studies were carried out in the presence of a 10-fold
excess of unlabeled competing ligand. Among the various
amino acids used, only L-methionine, L-cystine, and to a lesser
extent L-glutamic acid compete with the cysteine uptake (Table
3). The other tested amino acids (tryptophan, leucine, serine,
FIG. 4. L-Cysteine effect on the growth of Y. ruckeri parental and
cdsA mutant strains. Strains were grown under simulated anaerobic
conditions in M9GC (black symbols) and M9GC supplemented with
0.5 mM L-cysteine (white symbols). Œ and ‚, parental strain; f and ,
cdsA mutant. Growth curves were determined by three independent
experiments, and the media were represented. The standard deviations
were lower than 0.06.
TABLE 2. L-Cysteine remaining in the supernatant of cell cultures
of Y. ruckeri parental and cdsA and cdsB mutant strains after 48 h
of incubation in M9GC supplemented with 0.5 mM L-cysteine
Strain
L-Cysteine in
culture supernatant
(mg/ml)
Utilization of
L-cysteine
(mg/mg
protein)a
No cells 0.065  0.001
Y. ruckeri parental 0.005  0.002 1.02  0.09
Y. ruckeri cdsA mutant 0.038  0.001 0.27  0.08
Y. ruckeri cdsB mutant 0.006  0.003 0.89  0.08
a The utilization of L-cysteine was inferred per milligram of protein, consid-
ering the amount of this amino acid present at the end of the incubation period
in the culture medium without cells. The data represent the average of results
from three independent experiments.
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and threonine) had no effect on the cysteine uptake. The pres-
ence of the uncoupler of phosphorylation CCCP resulted in a
considerable loss in the cysteine uptake, which implies that
CdsA-mediated cysteine transport is an energy-dependent pro-
cess (Table 3).
The cdsAB operon is needed for full virulence of Y. ruckeri,
and it is conserved in different isolates. The fact that the Y.
ruckeri 150RiviX strain was obtained as an IVET clone sug-
gested that the cdsAB operon could have a role during the
infection process. To go further into this, in vivo competition
assays and LD50 experiments were carried out using the pa-
rental and the cdsA and cdsB strains. The competence indexes
(CI) obtained for in vivo experiments were 0.03  0.01 and
0.24  0.14 for the cdsA and cdsB mutants, respectively, which
indicated a significant lower recovery of cells of the mutant
strains than that of the parental strain. The results obtained in
LD50 experiments showed that the mutant strains showed sig-
nificantly higher values than those of the parental strain. Thus,
the means of LD50 values were 5.65  10
4 CFU/fish for the
parental strain and 1.18  106 and 3.55  105 CFU/fish for the
cdsA and cdsB mutants, respectively. Therefore, gene IVET
selection, together with the results obtained from in vivo CI
and LD50 experiments, confirmed that the cdsAB operon is
necessary for full virulence and thus for the development of the
infection process.
The presence of the cdsAB operon was analyzed by PCR in
15 different Y. ruckeri strains from different sources and ori-
gins. All of them showed the amplification of two bands of 756
bp and 549 bp, corresponding to internal fragments of cdsA
and cdsB, respectively (Fig. 6). This result indicates intraspe-
cies genetic homogeneity, given that the genes are present in
serotype I and II as well as recently isolated new biotype strains
from outbreaks in Spain.
DISCUSSION
Once more, IVET has allowed the in-depth investigation of
the pathogenic mechanisms of Y. ruckeri. In this case, analysis
of the sequences surrounding the iviX clone (11) revealed the
presence of two ORFs. Comparative analysis and functional
predictions indicated that they could represent a new system
involved in the uptake and further degradation of the amino
acid cysteine. Major clues were the presence in the CdsB pro-
tein of 28 out of 29 conserved amino acids of the L-cysteine
desulfidase of M. jannaschii (33) and the presence in CdsA of
a clear permease domain related to amino acid transporter
proteins.
In the present work, it is shown that L-cysteine desulfidase
orthologs were present in many facultative bacteria apart from
E. coli (33), such as C. koseri, Y. ruckeri, K. pneumoniae, and Y.
enterocolitica. Interestingly, unlike the L-cysteine desulfidase of
M. jannaschii, the CdsB protein of these species is preceded in
the genome by the permease CdsA. In fact, phylogenetic anal-
ysis based on the CdsB protein showed that these bacteria and
others which also harbor the cdsAB loci are grouped in the
same cluster, suggesting a common evolutionary origin. In
other species, such as Y. pestis and Y. pseudotuberculosis, down-
stream from a locus similar to cdsA is located metC, a gene
FIG. 5. Uptake of [35S]L-cysteine by Y. ruckeri parental and cdsA
mutant strains. L-Cysteine taken up by cells of parental (●) and cdsA
mutant (f) strains during a 5-min period. The data points represent
the mean values from three separate experiments.
TABLE 3. Effect of different compounds on L-cysteine transport by
cells of Y. ruckeri
Compound % uptake  SD
No inhibitor .............................................................................. 100
L-Cysteine ................................................................................. 43  12
L-Threonine .............................................................................. 98  9
L-Serine .....................................................................................109  3
L-Leucine .................................................................................. 75  16
L-Methionine ............................................................................ 39  10
L-Tryptophan............................................................................ 86  8
L-Glutamic acid........................................................................ 63  14
L-Cystinea .................................................................................. 51  14
CCCPb ....................................................................................... 36  1
DMSO....................................................................................... 95  12
a 
35SL-cysteine was used at a concentration of 200 M. All competitors were
added to a final concentration of 2 mM, a 10-fold excess over the labeled
substrate, except L-cystine, added in a final concentration of 200 M.
b Cells were preincubated with the metabolic inhibitor CCCP for 10 min
before addition of the 
35SL-cysteine. CCCP was dissolved in dimethyl sulfoxide
(DMSO), and hence this compound was analyzed for its effect on L-cysteine
uptake. The data represent the mean values from three independent experi-
ments. When 
35SL-cysteine was used at a concentration of 20 M and all the
competitors were added to a final concentration of 200 M, the results were
similar.
FIG. 6. PCR detection of cdsA and cdsB genes from different Y.
ruckeri strains. Independent PCRs were carried out for each gene. The
amplicons obtained were then mixed and separated in a 1.5% agarose
gel. The sizes of the amplicons generated were 756 bp and 549 bp for
cdsA and cdsB, respectively. Lanes: 2, strain 146; 3, strain 147; 4, strain
148; 5, strain 149; 6, strain 150; 7, strain 955; 8, strain 956; 9, strain
35/85; 10, strain 13/86; 11, strain 43/19; 12, strain A100; 13, strain A102;
14, strain 150/05; 15, strain 158/05; 16, strain 382/05; 17, negative
control. Lanes 1 and 18, DNA molecular size markers from 1,000 to
100 bp.
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involved in the degradation of L-cysteine to pyruvate, ammo-
nia, and sulfide in E. coli (3). The fact that cdsA appears
adjacent to two different enzymes which use L-cysteine as a
substrate reinforces the role of this protein as a cysteine per-
mease.
The relation of these two genes with the uptake and further
metabolism of L-cysteine was also supported by promoter in-
duction experiments, comparative toxic effect, and cysteine
consumption throughout the growth of parental and cdsA mu-
tant strains and also by the differential cell uptake of labeled
cysteine observed between the two strains.
In fact, promoter induction took place only in the presence
of cysteine. The induction detected when cystine was in the
culture medium seems to be a consequence of the conversion
of this amino acid to cysteine. This was supported by the
ninhydrin method, which detected high levels of cysteine in
culture supernatants when cystine was the only amino acid
included in the medium. The production of H2S as a metabo-
lite derived from cysteine and cystine utilization helped to keep
a reductive state, as was confirmed by measuring the redox
potential. On the contrary, under aerobic conditions, only lim-
ited induction was observed, probably due to the rapid con-
version of cysteine to cystine (10). The fact that in aerobic
conditions neither cysteine nor cystine produced significant
promoter induction strongly supports the idea that this operon
is induced specifically by cysteine. It should be emphasized that
the genes are found widely in anaerobic and facultative bacte-
ria but not in aerobic bacteria.
The analysis of mutations in cdsA and cdsB genes also sup-
ported the involvement of the cdsA gene in the uptake of
cysteine. The cysteine toxic effect defined by Kari et al. (18)
was lower in the cdsA mutant strain than in the parental and
csdB mutant strains, probably due to the lesser utilization of
cysteine by the cdsA mutant in the course of growth, just as was
shown by the ninhydrin method.
Finally, radiotracer studies confirmed the involvement of
cdsA in the uptake of L-cysteine in Y. ruckeri. Time course
results as well as L-cysteine consumption during the growth
curve suggested the existence of at least one additional cysteine
uptake system given the residual cysteine uptake in the cdsA
mutant. However, the comparative analyses of kinetic data in
different biological systems are complex and subject to multi-
ple factors. These, together with the special characteristics of
this amino acid (in oxidizing conditions, cystine is the com-
pound present in the environment), make extremely difficult
the estimate and comparison of specific kinetic parameters
between strains. These are the reasons information concerning
cysteine uptake in bacteria is sparse and few examples of cys-
teine transporters have been found. In Campylobacter jejuni,
CjaA is a receptor protein with a high affinity for L-cysteine
(24). In Legionella pneumophila as well as in Cyanobacterium
synechocystis, two cysteine transporters were identified (10,
32). In Saccharomyces cerevisiae, up to seven different per-
meases were described as taking up cysteine, and the uptake of
this amino acid was found to be a nonsaturable process under
various conditions (9).
The presence of cysteine desulfhydrases has been described
in different microorganisms. In Bacillus subtilis, four different
genes encoding this kind of enzyme have been found (2).
Interestingly, in E. coli, a quintet mutant strain in five different
cysteine desulfhydrases still showed some cysteine desulfhy-
drase activity (4). According to all the data, it seems that the
cdsAB system remained undiscovered because specific culture
conditions are needed for induction. It could represent one of
the systems responsible for the residual cysteine degradation
activity detected in this E. coli quintet mutant strain, given that
E. coli possesses an orthologous cdsAB operon.
It should be indicated that local reducing environments
caused by H2S generation could be present in the gut tract of
rainbow trout, one of the main locations of Y. ruckeri (14), as
a consequence of bacterial metabolism. H2S is also present in
other tissues (25), since this gas is considered to be a gaso-
transmitter able to trigger cell signaling in vertebrate animals,
including rainbow trout, with physiological levels of H2S in the
blood in the range from 10 to 300 M (8, 21). It is possible that
H2S reduces cystine to cysteine under these conditions, and
genes related to the transport and metabolism of this amino
acid might be induced. This CdsAB system might be involved
in the generation of iron-sulfur centers for proteins, as was
proposed for the L-cysteine desulfidase of M. jannaschii (33),
and also in glutathione accumulation, the major redox buffer
and detoxification molecule in the cell. In any case, the absence
of the CdsA and CdsB proteins led to bacterial attenuation as
well as a significantly restricting growth in the fish, showing
that this system is related to the progression of the bacteria
inside the animal during the infection process. According to
the presence of the cdsAB operon in different pathogenic spe-
cies, it is probable that its involvement in the infection process
is not exclusive to Y. ruckeri.
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